000 | 01157 a2200349 4500 | ||
---|---|---|---|
005 | 20250512200039.0 | ||
264 | 0 | _c19831021 | |
008 | 198310s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(83)92563-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiranda, D R | |
245 | 0 | 0 |
_aEtomidate in the intensive care unit. _h[electronic resource] |
260 |
_bLancet (London, England) _cSep 1983 |
||
300 |
_a684-5 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xpharmacology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBenzodiazepines _xpharmacology |
650 | 0 | 4 |
_aEtomidate _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xadverse effects |
650 | 0 | 4 |
_aInfections _xepidemiology |
650 | 0 | 4 | _aIntensive Care Units |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMorphine _xpharmacology |
650 | 0 | 4 |
_aWounds and Injuries _ximmunology |
700 | 1 | _aStoutenbeek, C P | |
773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8351 _gp. 684-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(83)92563-1 _zAvailable from publisher's website |
999 |
_c6136904 _d6136904 |